July 17, 2013 3:14 am
|
|
|---|---|
|
|
| LAMOTRIGINE |
PARSIPPANY, N.J., July 15, 2013 (AP) — Drugmaker Actavis Inc. said Monday it’s received U.S. approval to sell a generic version of Lamictal, a tablet for treating epilepsy and bipolar disorder.
Actavis, based in Parsippany, N.J., said the Food and Drug Administration has granted approval for it to sell lamotrigine tablets in doses of 25, 50, 100 and 200 milligrams.http://www.pharmalive.com/actavis-to-launch-generic-epilepsybipolar-drug
Lamotrigine, marketed in the US and most of Europe as Lamictal /ləˈmɪktəl/ byGlaxoSmithKline, is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder. It is also used off-label as an adjunct in treating depression. For epilepsy, it is used to treat focal seizures, primary and secondary tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Like many other anticonvulsant medications, Lamotrigine also seems to act as an effective mood stabilizer, and has been the first U.S.Food and Drug Administration (FDA)-approved drug for this purpose since lithium, a drug approved almost 30 years earlier. It is approved for the maintenance treatment of bipolar type I. Chemically unrelated to other anticonvulsants (due to lamotrigine’s being aphenyltriazine), lamotrigine has many possible side-effects. Lamotrigine is generally accepted to be a member of the sodium channel blocking class of antiepileptic drugs,but it could have additional actions since it has a broader spectrum of action than other sodium channel antiepileptic drugs such as phenytoin and carbamazepine and is effective in the treatment of the depressed phase of bipolar disorder, whereas other sodium channel blocking antiepileptic drugs are not. In addition, lamotrigine shares few side-effects with other, unrelated anticonvulsants known to inhibit sodium channels, which further emphasizes its unique properties. Lamotrigine is inactivated by hepatic glucuronidation.
Posted by DR ANTHONY MELVIN CRASTO Ph.D
Categories: GENERIC DRUG
Tags: Actavis, Anthony crasto, AYURVEDA, Bipolar Drug, drugs, Epilepsy, fda, GENERIC, GMP, herbs, Lamictal, LAMOTRIGINE, Launch, manufacturing, medicinal chemistry, organic chemistry, organic synthesis, PROCESS, world drug tracker
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.
Reblogged this on MedCheminAustralia.
LikeLike
By medchemnintabelle on July 17, 2013 at 7:50 am
Reblogged this on MEDCHEMEGYPT.
LikeLike
By saminakhan2001 on July 18, 2013 at 4:12 am
Reblogged this on Srilanka-Chem.
LikeLike
By srilankachem on July 18, 2013 at 4:13 am
Reblogged this on MED.CHEM in BURMA.
LikeLike
By sonsondaimari on July 18, 2013 at 4:14 am
Reblogged this on MED.CHEM in BURMA.
LikeLike
By sonsondaimari on July 18, 2013 at 4:14 am
Reblogged this on GREEN MED CHEMISTRY.
LikeLike
By sarakinsley on July 18, 2013 at 4:15 am
Reblogged this on My Blog on Medicinal Chemistry.
LikeLike
By sachinsurvey1980 on July 18, 2013 at 4:15 am
Reblogged this on MariaGairos–DRUGS.
LikeLike
By mariagairos on July 18, 2013 at 4:17 am
Reblogged this on Vijaya Shastry Ph.D Physical Chemistry.
LikeLike
By vijayashastry on July 18, 2013 at 4:18 am